Back
The Beauty Health Quote, Financials, Valuation and Earnings
Sponsored
SKIN
Sponsored
Election Shock on August 19th?
Click here now to see the evidence I've gathered.
Sell
16
SKIN
The Beauty Health
Last Price:
3.24
Seasonality Move:
15.04%
7 Day Trial
ALL ACCESS PASS
$
7
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.The Beauty Health Price Quote
$3.24
The Beauty Health Key Stats
Sell
16
The Beauty Health (SKIN)
is a Sell
Day range:
$3.03 - $3.34
52-week range:
$1.35 - $11.73
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.07
P/B ratio:
6.73%
Volume:
1.4M
Avg. volume:
1.9M
1-year change:
-71.17%
Market cap:
$399.9M
Revenue:
$398M
EPS:
$-0.78
How Much Does The Beauty Health Make?
-
How Much Are The Beauty Health's Sales Annually?
SKIN Revenues are $398M -
How Much Profit Does The Beauty Health's Make A Year?
SKIN net income is -$100.1M
Is The Beauty Health Growing As A Company?
-
What Is The Beauty Health's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.01% -
What Is The Beauty Health's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
The Beauty Health Stock Price Performance
-
Did The Beauty Health Stock Go Up Last Month?
The Beauty Health share price went down by -25.52% last month -
Did SKIN's Share Price Rise Over The Last Year?
SKIN share price fell by -71.17% over the past 1 year
What Is The Beauty Health 52-Week High & Low?
-
What Is The Beauty Health’s 52-Week High Share Price?
The Beauty Health has traded as high as $11.73 over the past 52 weeks -
What Is The Beauty Health’s 52-Week Low Share Price?
The Beauty Health has traded as low as $1.35 over the past 52 weeks
The Beauty Health Price To Free Cash Flow
-
Is The Beauty Health Stock Overvalued?
The Beauty Health is trading at a price to free cash flow ratio of 49.03 -
Is The Beauty Health Stock Undervalued?
The Beauty Health EV to Free Cash Flow ratio is 70.71 -
What Is The Beauty Health’s Price Earnings Growth Ratio?
SKIN PEG ratio is -0.01 -
Is The Beauty Health Trading At A Premium To Earnings?
The Beauty Health EV to EBIT ratio is 0.00
Is It Risky To Buy The Beauty Health?
-
How Much Debt Does The Beauty Health Have?
Total long term debt quarterly is $738.4M -
How Much Cash Does The Beauty Health Have?
Cash and short term investments quarterly total is $523M -
What Is The Beauty Health’s Book Value Per Share?
Book value per share is 0.48
Is The Beauty Health Cash Flow Positive?
-
What Is SKIN Cash Flow From Operations?
Cash flow from operations (TTM) is $21.8M -
What Is The Beauty Health’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$37.4M -
What Is The Beauty Health’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$31.5M
The Beauty Health Return On Invested Capital
-
Is Management Doing A Good Job?
SKIN return on invested capital is -11.86% -
What Is The Beauty Health Return On Assets?
ROA measures how assets are converting to revenues and is -10.41% -
What Is SKIN Return On Equity?
ROE is a measure of profitability and is -81.6%
The Beauty Health Earnings Date & Stock Price
-
What Is The Beauty Health's Stock Price Today?
A single share of SKIN can be purchased today for 3.24 -
What Is The Beauty Health’s Stock Symbol?
The Beauty Health trades on the nasdaq under the ticker symbol: SKIN -
When Is The Beauty Health’s Next Earnings Date?
The next quarterly earnings date for The Beauty Health is scheduled on May 10, 2024 -
When Is SKIN's next ex-dividend date?
The Beauty Health's next ex-dividend date is April 28, 2024 -
How To Buy The Beauty Health Stock?
You can buy The Beauty Health shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
The Beauty Health Competitors
-
Who Are The Beauty Health's Competitors?
Below is a list of companies who compete with The Beauty Health or are related in some way:
The Beauty Health Dividend Yield
Data Unavailable
The Beauty Health Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 115.21% |
Revenue: | -1.34% | 10.49% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 7 |
Sell Recommendations: | 0 |
Price Target: | 4.49 |
Upside from Last Price: | 38.58% |